#obesity-management

[ follow ]
#glp-1-medications #weight-regain #who-guidelines #weight-loss #clinical-trials #eli-lilly #health-benefits
Public health
fromInsideHook
1 week ago

Research Suggests GLP-1 Drugs Could Be for the Long Haul

People using GLP-1 weight-loss medications often require long-term or lifelong treatment because stopping them commonly leads to rapid weight regain and lost metabolic benefits.
fromwww.theguardian.com
5 months ago

Daily pill helps patients lose 12% of body weight in early trial

The drug orforglipron, developed by Eli Lilly, is a GLP-1 agonist that has shown in trials to help patients lose about 12% of their body weight.
Healthcare
[ Load more ]